CVS Health Corp. (CVS)
87.72
-2.07
(-2.31%)
USD |
NYSE |
Nov 13, 12:59
CVS Health EPS Diluted (Quarterly) : 1.682 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.682 |
| June 30, 2026 | 2.315 |
| March 31, 2026 | 2.301 |
| December 31, 2025 | 2.305 |
| September 30, 2025 | -3.132 |
| June 30, 2025 | 0.8039 |
| March 31, 2025 | 1.407 |
| December 31, 2024 | 1.304 |
| September 30, 2024 | 0.0691 |
| June 30, 2024 | 1.406 |
| March 31, 2024 | 0.8784 |
| December 31, 2023 | 1.582 |
| September 30, 2023 | 1.753 |
| June 30, 2023 | 1.477 |
| March 31, 2023 | 1.654 |
| December 31, 2022 | 1.770 |
| September 30, 2022 | -2.590 |
| June 30, 2022 | 2.293 |
| March 31, 2022 | 1.773 |
| December 31, 2021 | 0.98 |
| September 30, 2021 | 1.202 |
| June 30, 2021 | 2.097 |
| March 31, 2021 | 1.682 |
| December 31, 2020 | 0.7388 |
| September 30, 2020 | 0.9308 |
| Date | Value |
|---|---|
| June 30, 2020 | 2.264 |
| March 31, 2020 | 1.530 |
| December 31, 2019 | 1.332 |
| September 30, 2019 | 1.172 |
| June 30, 2019 | 1.49 |
| March 31, 2019 | 1.09 |
| December 31, 2018 | -0.37 |
| September 30, 2018 | 1.362 |
| June 30, 2018 | -2.52 |
| March 31, 2018 | 0.98 |
| December 31, 2017 | 3.22 |
| September 30, 2017 | 1.26 |
| June 30, 2017 | 1.07 |
| March 31, 2017 | 0.92 |
| December 31, 2016 | 1.59 |
| September 30, 2016 | 1.43 |
| June 30, 2016 | 0.86 |
| March 31, 2016 | 1.04 |
| December 31, 2015 | 1.329 |
| September 30, 2015 | 1.11 |
| June 30, 2015 | 1.12 |
| March 31, 2015 | 1.07 |
| December 31, 2014 | 1.144 |
| September 30, 2014 | 0.81 |
| June 30, 2014 | 1.06 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| The Cigna Group | 5.466 |
| Centene Corp. | -0.1437 |
| Humana, Inc. | 1.330 |
| Molina Healthcare, Inc. | 0.7379 |
| UnitedHealth Group, Inc. | 4.556 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.171B |
| Revenue (Quarterly) | 108.40B |
| Total Expenses (Quarterly) | 106.22B |
| Enterprise Value | 175.53B |
| Gross Profit Margin (Quarterly) | 13.74% |
| Profit Margin (Quarterly) | 2.00% |
| Earnings Yield | 9.81% |
| Operating Earnings Yield | 13.61% |
| Normalized Earnings Yield | 9.966 |